Gene: ACTRT3
Official Full Name: actin related protein T3provided by HGNC
Gene Summary: Predicted to be located in cytoplasm; cytoskeleton; and male germ cell nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24834 | ACTRT3 Knockout cell line (HeLa) | Human | ACTRT3 | 1:3~1:6 | Negative | Online Inquiry |
KO24835 | ACTRT3 Knockout cell line (HCT 116) | Human | ACTRT3 | 1:2~1:4 | Negative | Online Inquiry |
KO24836 | ACTRT3 Knockout cell line (HEK293) | Human | ACTRT3 | 1:3~1:6 | Negative | Online Inquiry |
KO24837 | ACTRT3 Knockout cell line (A549) | Human | ACTRT3 | 1:3~1:4 | Negative | Online Inquiry |
ACTRT3 Gene Knockout Cell Lines are precision-engineered cellular models specifically designed to facilitate the comprehensive study of the ACTRT3 gene's role in cellular processes. Utilized in both academic research and clinical settings, these cell lines have been meticulously developed through advanced CRISPR-Cas9 gene-editing technology, enabling the targeted disruption of ACTRT3 gene expression. This targeted knockout allows researchers to observe the resultant phenotypic and functional changes in cell behavior, apoptosis, migration, and proliferation, thereby elucidating the gene's biological significance.
The key function of ACTRT3 gene knockout cell lines lies in their ability to simulate the loss-of-function scenarios critical for the investigation of gene functions in development and disease. By removing the ACTRT3 gene, which is implicated in cytoskeletal organization and cellular signaling pathways, researchers can analyze downstream effects on cellular dynamics and pathophysiological conditions. This gene knockout model is invaluable for dissecting the molecular mechanisms behind various diseases, including cancer and developmental disorders.
The scientific importance of these cell lines goes beyond basic research; they serve as a vital tool for drug screening and therapeutic assessments. For instance, understanding the nuances of ACTRT3 activity can lead to the identification of potential drug targets, providing a pathway for novel treatment strategies. Compared to traditional models, ACTRT3 knockout cell lines offer higher specificity and reproducibility, reducing variability that may arise from using heterogeneous cell populations.
A distinctive advantage of incorporating our ACTRT3 knockout cell lines into research protocols is their user-friendly application and cost-effectiveness, paired with robust validation processes that ensure high-quality, consistent results. Additionally, unlike some existing alternatives, our product comes with comprehensive support and guidance to facilitate optimal use and experimentation.
As a leader in biological product development, our company prides itself on our expertise in gene editing technologies and cellular biology. We are dedicated to providing innovative tools that empower researchers and clinicians to unlock new biological insights and advance therapeutic strategies. With ACTRT3 Gene Knockout Cell Lines, you can explore the frontiers of molecular research with confidence and precision.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.